BHV-1-specific CD4+, CD8+, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine

Janice Endsley, Mark J. Quade, Brett Terhaar, James A. Roth

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Expression of the high-affinity interleukin 2 receptor α chain (CD25) was used to monitor antigen-specific activation of T lymphocyte subsets (CD4+, CD8+, and γδ T cells) from cattle immunized with modified live bovine herpesvirus-1 (BHV-1). Calves seronegative for BHV-1 were either vaccinated with one dose of modified live vaccine containing BHV-1 or not vaccinated to serve as negative controls. Two animals vaccinated 7 and 5 weeks before the start of the experiment with two doses of modified live vaccine containing BHV-1 served as positive controls. Blood samples were taken from the nonvaccinate group, the positive control group, and the vaccinate group at 0, 21, 35, 60, and 90 days postinoculation (PI). Isolated peripheral blood mononuclear cells from immunized and control animals were incubated for 5 days with and without live BHV-1 ISU99. Compared to the nonvaccinates, a significant (p < 0.05) increase in expression of CD25 by CD4+, CD8+, and γδ T lymphocytes from the vaccinate group was detected following in vitro exposure to live BHV-1 after vaccination. This is apparently the first report using live BHV-1 to stimulate lymphocytes in vitro and showing CD8+ T cell activation. Peripheral blood from the positive control animals was depleted of CD4+, CD8+, or γδ T lymphocytes prior to incubation with BHV-1 to assess bystander activation in the CD25 expression assay. When incubated with live BHV-1, depletion of CD4+ T cells depressed the expression of CD25 by CD8+ T cells, but not γδ T cells. Depleting CD8+ or γδ T cells prior to in vitro culture with BHV-1 did not affect the expression of CD25 by the remaining T lymphocyte subsets. Vaccinates were protected from challenge with virulent BHV-1 at 110 days postvaccination compared to nonvaccinates. Expression of CD25 appears to be a useful marker for evaluating induction of antigen-specific T lymphocyte subset responses following vaccination.

Original languageEnglish (US)
Pages (from-to)385-393
Number of pages9
JournalViral Immunology
Volume15
Issue number2
StatePublished - 2002
Externally publishedYes

Fingerprint

Herpesvirus Vaccines
Bovine Herpesvirus 1
T-Lymphocytes
T-Lymphocyte Subsets
Vaccination
Vaccines
Antigens
Interleukin-2 Receptors

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

BHV-1-specific CD4+, CD8+, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine. / Endsley, Janice; Quade, Mark J.; Terhaar, Brett; Roth, James A.

In: Viral Immunology, Vol. 15, No. 2, 2002, p. 385-393.

Research output: Contribution to journalArticle

Endsley, Janice ; Quade, Mark J. ; Terhaar, Brett ; Roth, James A. / BHV-1-specific CD4+, CD8+, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine. In: Viral Immunology. 2002 ; Vol. 15, No. 2. pp. 385-393.
@article{39d4378a1a9d4614b470c57a1563051e,
title = "BHV-1-specific CD4+, CD8+, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine",
abstract = "Expression of the high-affinity interleukin 2 receptor α chain (CD25) was used to monitor antigen-specific activation of T lymphocyte subsets (CD4+, CD8+, and γδ T cells) from cattle immunized with modified live bovine herpesvirus-1 (BHV-1). Calves seronegative for BHV-1 were either vaccinated with one dose of modified live vaccine containing BHV-1 or not vaccinated to serve as negative controls. Two animals vaccinated 7 and 5 weeks before the start of the experiment with two doses of modified live vaccine containing BHV-1 served as positive controls. Blood samples were taken from the nonvaccinate group, the positive control group, and the vaccinate group at 0, 21, 35, 60, and 90 days postinoculation (PI). Isolated peripheral blood mononuclear cells from immunized and control animals were incubated for 5 days with and without live BHV-1 ISU99. Compared to the nonvaccinates, a significant (p < 0.05) increase in expression of CD25 by CD4+, CD8+, and γδ T lymphocytes from the vaccinate group was detected following in vitro exposure to live BHV-1 after vaccination. This is apparently the first report using live BHV-1 to stimulate lymphocytes in vitro and showing CD8+ T cell activation. Peripheral blood from the positive control animals was depleted of CD4+, CD8+, or γδ T lymphocytes prior to incubation with BHV-1 to assess bystander activation in the CD25 expression assay. When incubated with live BHV-1, depletion of CD4+ T cells depressed the expression of CD25 by CD8+ T cells, but not γδ T cells. Depleting CD8+ or γδ T cells prior to in vitro culture with BHV-1 did not affect the expression of CD25 by the remaining T lymphocyte subsets. Vaccinates were protected from challenge with virulent BHV-1 at 110 days postvaccination compared to nonvaccinates. Expression of CD25 appears to be a useful marker for evaluating induction of antigen-specific T lymphocyte subset responses following vaccination.",
author = "Janice Endsley and Quade, {Mark J.} and Brett Terhaar and Roth, {James A.}",
year = "2002",
language = "English (US)",
volume = "15",
pages = "385--393",
journal = "Viral Immunology",
issn = "0882-8245",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - BHV-1-specific CD4+, CD8+, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine

AU - Endsley, Janice

AU - Quade, Mark J.

AU - Terhaar, Brett

AU - Roth, James A.

PY - 2002

Y1 - 2002

N2 - Expression of the high-affinity interleukin 2 receptor α chain (CD25) was used to monitor antigen-specific activation of T lymphocyte subsets (CD4+, CD8+, and γδ T cells) from cattle immunized with modified live bovine herpesvirus-1 (BHV-1). Calves seronegative for BHV-1 were either vaccinated with one dose of modified live vaccine containing BHV-1 or not vaccinated to serve as negative controls. Two animals vaccinated 7 and 5 weeks before the start of the experiment with two doses of modified live vaccine containing BHV-1 served as positive controls. Blood samples were taken from the nonvaccinate group, the positive control group, and the vaccinate group at 0, 21, 35, 60, and 90 days postinoculation (PI). Isolated peripheral blood mononuclear cells from immunized and control animals were incubated for 5 days with and without live BHV-1 ISU99. Compared to the nonvaccinates, a significant (p < 0.05) increase in expression of CD25 by CD4+, CD8+, and γδ T lymphocytes from the vaccinate group was detected following in vitro exposure to live BHV-1 after vaccination. This is apparently the first report using live BHV-1 to stimulate lymphocytes in vitro and showing CD8+ T cell activation. Peripheral blood from the positive control animals was depleted of CD4+, CD8+, or γδ T lymphocytes prior to incubation with BHV-1 to assess bystander activation in the CD25 expression assay. When incubated with live BHV-1, depletion of CD4+ T cells depressed the expression of CD25 by CD8+ T cells, but not γδ T cells. Depleting CD8+ or γδ T cells prior to in vitro culture with BHV-1 did not affect the expression of CD25 by the remaining T lymphocyte subsets. Vaccinates were protected from challenge with virulent BHV-1 at 110 days postvaccination compared to nonvaccinates. Expression of CD25 appears to be a useful marker for evaluating induction of antigen-specific T lymphocyte subset responses following vaccination.

AB - Expression of the high-affinity interleukin 2 receptor α chain (CD25) was used to monitor antigen-specific activation of T lymphocyte subsets (CD4+, CD8+, and γδ T cells) from cattle immunized with modified live bovine herpesvirus-1 (BHV-1). Calves seronegative for BHV-1 were either vaccinated with one dose of modified live vaccine containing BHV-1 or not vaccinated to serve as negative controls. Two animals vaccinated 7 and 5 weeks before the start of the experiment with two doses of modified live vaccine containing BHV-1 served as positive controls. Blood samples were taken from the nonvaccinate group, the positive control group, and the vaccinate group at 0, 21, 35, 60, and 90 days postinoculation (PI). Isolated peripheral blood mononuclear cells from immunized and control animals were incubated for 5 days with and without live BHV-1 ISU99. Compared to the nonvaccinates, a significant (p < 0.05) increase in expression of CD25 by CD4+, CD8+, and γδ T lymphocytes from the vaccinate group was detected following in vitro exposure to live BHV-1 after vaccination. This is apparently the first report using live BHV-1 to stimulate lymphocytes in vitro and showing CD8+ T cell activation. Peripheral blood from the positive control animals was depleted of CD4+, CD8+, or γδ T lymphocytes prior to incubation with BHV-1 to assess bystander activation in the CD25 expression assay. When incubated with live BHV-1, depletion of CD4+ T cells depressed the expression of CD25 by CD8+ T cells, but not γδ T cells. Depleting CD8+ or γδ T cells prior to in vitro culture with BHV-1 did not affect the expression of CD25 by the remaining T lymphocyte subsets. Vaccinates were protected from challenge with virulent BHV-1 at 110 days postvaccination compared to nonvaccinates. Expression of CD25 appears to be a useful marker for evaluating induction of antigen-specific T lymphocyte subset responses following vaccination.

UR - http://www.scopus.com/inward/record.url?scp=0035987469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035987469&partnerID=8YFLogxK

M3 - Article

C2 - 12081020

AN - SCOPUS:0035987469

VL - 15

SP - 385

EP - 393

JO - Viral Immunology

JF - Viral Immunology

SN - 0882-8245

IS - 2

ER -